MedtechQuality
Starting to get Involved
I was talking with a friend who works in medical device manufacturing, and he brought up an interesting scenario around sampling plans and cost reduction.
The setup was this:
The company has a documented procedure that requires AQL-based sampling during final inspection. For the past two years, they’ve collected inspection data and found zero defects in the sampled lots. Now there’s a push from management to reduce cost and improve efficiency, so the question becomes:
With two years of clean data, how would you justify reducing or even eliminating that final inspection sampling plan, without compromising quality or compliance?
I would love to gain some traction for the above scenario. Please share your approach/solution/perspective.
Thanks,
The setup was this:
The company has a documented procedure that requires AQL-based sampling during final inspection. For the past two years, they’ve collected inspection data and found zero defects in the sampled lots. Now there’s a push from management to reduce cost and improve efficiency, so the question becomes:
With two years of clean data, how would you justify reducing or even eliminating that final inspection sampling plan, without compromising quality or compliance?
I would love to gain some traction for the above scenario. Please share your approach/solution/perspective.
Thanks,